This document describes the design and results of the validation exercise for the Rapid Estrogen ACTivity In Vivo (REACTIV) Assay, organised by France and the United Kingdom. This method was developed for the detection of estrogen axis active substances. The project was on the Test Guidelines Programme work plan until 2024.
Validation report for the Test Guideline 252 on the Rapid Estrogen ACTivity In Vivo (REACTIV) Assay
Report
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
10 August 2026179 Pages
-
Report10 August 202653 Pages
-
15 December 2025169 Pages
-
Report3 December 2025136 Pages
Related publications
-
10 August 2026179 Pages
-
Report10 August 202653 Pages
-
Report
Assay for the Detection of Glucocorticoid Receptor Agonist and Antagonist Activity of Chemicals
2 July 202634 Pages -
2 July 202651 Pages
-
2 July 2026115 Pages